AAMU
NVAX icon

Amundi Asset Management US’s Novavax NVAX Stock Holding History

Amundi Asset Management US’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		$799K Sell
4,406
-894
-17% -$178K ﹤0.01% 1278
2020
Q4 		$591K Hold
5,300
– – ﹤0.01% 1270
2020
Q3 		$574K Hold
5,300
– – ﹤0.01% 1243
2020
Q2 		$442K Buy
+5,300
New +$203K ﹤0.01% 1267

Other funds holding NVAX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Amundi Asset Management US's NVAX Position: Q1 2021 in Review

Amundi Asset Management US reduced its Novavax (NVAX) stake by 17% in Q1 2021, selling an estimated $178K and leaving 4,406 shares worth $799K. The position accounts for ﹤0.01% of the portfolio, ranked #1278.

Amundi Asset Management US first reported a position in NVAX in Q2 2020 and has held it in 4 quarters since. 390 funds tracked by Wall St. Rank hold NVAX as of Q1 2021.

  • Amundi Asset Management US held 4,406 shares of Novavax worth $799K as of Q1 2021.
  • Amundi Asset Management US sold 894 Novavax shares in Q1 2021, an estimated $178K.
  • Novavax made up ﹤0.01% of Amundi Asset Management US's portfolio in Q1 2021, its #1278 holding.
  • Amundi Asset Management US first reported a position in Novavax in Q2 2020 and has held it in 4 quarters since.
  • 390 funds tracked by Wall St. Rank held Novavax as of Q1 2021.

Based on Amundi Asset Management US's 13F filing for Q1 2021, filed 17 May 2021.